Latest News on Glenmark pharma
Showing of 0 - 10 from 12 results
Glenmark pharma - Total results - 12
May 29, 2017
Glenmark Pharma gets USFDA approval to manufacture generic version of hypertension drug BystolicAccording to IMS Health sales data for the 12 months to March 2017, the Bystolic tablets achieved annual sales of approximately $1 billion
Sep 19, 2016
Glenmark, Particle Sciences enter deal to develop generic cancer drugAs per the terms of the agreement, Glenmark has obtained global exclusive marketing and distribution rights of the product upon commercialisation
Jul 18, 2016
Glenmark Pharma to raise over Rs 1,300 cr via bonds issuance to repay debtThese bonds are planned to be listed on the Singapore Stock Exchange
Jun 24, 2016
Glenmark receives USFDA approval for anti-fungal ointmentAccording to IMS Health sales data for the 12 months to April 2016, Glenmark said Nystatin and triamcinolone acetonide ointment achieved annual sales of around $37.5 million
Feb 24, 2016
Glenmark's US arm receives US FDA approval for contraceptive tabletsArray
Oct 30, 2015
Glenmark gets tentative USFDA approval for Lacosamide tabletsLacosamide Tablets is generic version of Vimpat Tablets of UCB Inc
Jun 17, 2015
Glenmark Pharma on roll, hits new 52-week high on spate of recent approvalsIn addition to today's gains, the stock has rallied 15 percent so far in last six trading sessions
Oct 03, 2013
10 things you need to know before the opening bellWall Street retreated on Wednesday, the second day of a partial U.S. government shutdown, as political wrangling in Washington raised investor concerns that the stoppage could be prolonged.
Jun 27, 2013
Sensex up 300 pts as lower CAD boosts mood, gas firms rallyThe BSE Sensex closes at 18868.15, up 1.70, while the Nifty closed at 5682.35, up 1.68 percent.
Dec 24, 2012
Sensex ends flat; Kingfisher up 5% as co submits revival planThe Indian equity markets ended flat in subdued trade due to lack of global and domestic triggers ahead of Christmas holiday.